| Literature DB >> 28270599 |
Davit Jishkariani1, Christopher M MacDermaid2, Yam N Timsina1, Silvia Grama1, Syeda S Gillani1, Masoumeh Divar1, Srujana S Yadavalli3, Ralph-Olivier Moussodia1, Pawaret Leowanawat1, Angely M Berrios Camacho1, Ricardo Walter4, Mark Goulian3, Michael L Klein5, Virgil Percec6.
Abstract
2,2-Bis(azidomethyl)propionic acid was prepared in four steps and 85% yield from the commercially available 2,2-bis(hydroxymethyl)propionic acid and used as the starting building block for the divergent, convergent, and double-stage convergent-divergent iterative methods for the synthesis of dendrimers and dendrons containing ethylenediamine (EDA), piperazine (PPZ), and methyl 2,2-bis(aminomethyl)propionate (COOMe) cores. These cores have the same multiplicity but different conformations. A diversity of synthetic methods were used for the synthesis of dendrimers and dendrons. Regardless of the method used, a self-interruption of the synthesis was observed at generation 4 for the dendrimer with an EDA core and at generation 5 for the one with a PPZ core, whereas for the COOMe core, self-interruption was observed at generation 6 dendron, which is equivalent to generation 5 dendrimer. Molecular modeling and molecular-dynamics simulations demonstrated that the observed self-interruption is determined by the backfolding of the azide groups at the periphery of the dendrimer. The latter conformation inhibits completely the heterogeneous hydrogenation of the azide groups catalyzed by 10% Pd/carbon as well as homogeneous hydrogenation by the Staudinger method. These self-terminated polyamide dendrimers are enzymatically and hydrolytically stable and also exhibit antimicrobial activity. Thus, these nanoscale constructs open avenues for biomedical applications.Entities:
Keywords: antimicrobials; dendrons; ethylenediamine core; nanomedicine; piperazine core
Mesh:
Substances:
Year: 2017 PMID: 28270599 PMCID: PMC5373347 DOI: 10.1073/pnas.1700922114
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205